Last reviewed · How we verify
NCT07128849
Effect of Phase I Cardiac Rehab With or Without Upper Limb Cycle Ergometer
NA trial testing upper limb exercise with arm ergometer in CAD in 44 participants. Currently enrolling.
30 November 2025
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 44 |
| Start date | 17 July 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- upper limb exercise with arm ergometer
- upper limb exercise with out arm ergometer
Conditions studied
- CAD — all drugs for CAD →
Sponsor
Riphah International University
Who can join
Adults 40 to 65, any sex, with CAD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to investigate the effects of an upper limb cycle ergometer in phase I CABG patients. This will likely enhance various outcomes such as quality of life, dyspnea, functional outcome measure, cardiovascular parameters, and upper limb mobility. If utilized, the arm ergometer may contribute to improve upper limb strength and endurance. This could result in improving upper limb range of motion and reducing the risk of adhesive capsulitis. This study will positively impact society by reducing morbidity and mortality rates, healthcare costs and ultimately improves patient care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07128849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CAD
Currently open trials in the same condition.
- NCT07205757 — Adding Lidocaine to Custodiol Mixture · Phase 4 · recruiting
- NCT05344612 — Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD · NA · recruiting
- NCT03331380 — Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scan · NA · recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07128849 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07128849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing